Phase 1/1b trial of fruquintinib in patients with advanced solid tumors: Preliminary results of the dose expansion cohorts in refractory metastatic colorectal cancer

被引：1
|
作者：
Dasari, Arvind
Hubbard, Joleen M.
Eng, Cathy
Yeckes-Rodin, Heather
Ukrainskyj, Stacey M.
Yang, Zhao
Schelman, William R.
Kania, Marek K.
Bekaii-Saab, Tanios S.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Mayo Clin, Rochester, MN USA
[3] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
[4] Cleveland Clin Florida, Port St Lucie, FL USA
[5] HUTCHMED Int, Shanghai, Peoples R China
[6] HUTCHMED Int, Florham Pk, NJ USA
[7] Mayo Clin, Div Hematol Oncol, Phoenix, AZ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 04期
关键词：
D O I：
10.1200/JCO.2022.40.4_suppl.093
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
93
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Phase (Ph) I/Ib trial of fruquintinib (fru) in patients (pts) with advanced solid tumors: Preliminary results of the dose expansion (exp) cohort in refractory metastatic colorectal cancer (mCRC)
    Dasari, N. A.
    Wang-Gillam, A.
    Hubbard, J. M.
    Fernandez, A.
    Nanda, S.
    Kania, M.
    Schelman, W. R.
    Bekaii-Saab, T. S.
    ANNALS OF ONCOLOGY, 2020, 31 : S436 - S437
  • [2] Preliminary Results of a Phase 1b Study of Fruquintinib Plus Sintilimab in Advanced Colorectal Cancer
    Bekaii-Saab, Tanios S.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (09) : 8 - 8
  • [3] Preliminary results of a phase 1b study of fruquintinib plus sintilimab in advanced colorectal cancer.
    Guo, Ye
    Zhang, Weijie
    Ying, Jieer
    Zhang, Yanqiao
    Pan, Yueyin
    Qiu, Wensheng
    Su, Weiguo
    Tan, Panfeng
    Yin, Hongyan
    Wang, Yan
    Luo, Yang
    Zhou, Hui
    Li, Jin
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [4] Phase 1b/2 trial of fruquintinib plus sintilimab in treating advanced solid tumours: The dose-escalation and metastatic colorectal cancer cohort in the dose-expansion phases
    Guo, Ye
    Zhang, Weijie
    Ying, Jieer
    Zhang, Yanqiao
    Pan, Yueyin
    Qiu, Wensheng
    Fan, Qingxia
    Xu, Qi
    Ma, Yue
    Wang, Gang
    Guo, Jing
    Su, Weiguo
    Fan, Songhua
    Tan, Panfeng
    Wang, Yan
    Luo, Yang
    Zhou, Hui
    Li, Jin
    EUROPEAN JOURNAL OF CANCER, 2023, 181 : 26 - 37
  • [5] Phase I trial of fruquintinib in patients with advanced solid tumors; Results of the dose escalation phase
    Wang-Gillam, A.
    Yeckes-Rodin, H.
    Kosmo, M. A.
    Stanton, T.
    Park, H.
    Songhua, F.
    Sauter, N. P.
    Kania, M.
    ANNALS OF ONCOLOGY, 2019, 30 : 175 - +
  • [6] Phase 1/1b open-label, dose-escalation study of fruquintinib in patients with advanced solid tumors in the United States
    Wang-Gillam, Andrea
    Schelman, William
    Ukrainskyj, Stacey
    Chien, Caly
    Gonzalez, Martha
    Yang, Zhao
    Kania, Marek
    Yeckes-Rodin, Heather
    INVESTIGATIONAL NEW DRUGS, 2023, 41 (06) : 851 - 860
  • [7] Phase 1/1b open-label, dose-escalation study of fruquintinib in patients with advanced solid tumors in the United States
    Andrea Wang-Gillam
    William Schelman
    Stacey Ukrainskyj
    Caly Chien
    Martha Gonzalez
    Zhao Yang
    Marek Kania
    Heather Yeckes-Rodin
    Investigational New Drugs, 2023, 41 (6) : 851 - 860
  • [8] Safety and preliminary activity of naptumomab estafenatox (NAP) and durvalumab in patients with advanced or metastatic solid tumors: interim results from a phase 1b trial
    Geva, Ravit
    Stemmer, Salomon
    Perets, Ruth
    Maurice-Dror, Corinne
    Ben-Ami, Eitan
    Raphael, Ari
    Kumar, Sanjeev
    Lorber, Ilana
    Kedem, Tal Hetzroni
    Fields, Scott Z.
    Rozencweig, Marcel
    Golan, Talia
    CANCER RESEARCH, 2023, 83 (08)
  • [9] A phase 1b expansion study of TAS-102 with oxaliplatin for refractory metastatic colorectal cancer
    Cecchini, Michael
    Kortmansky, Jeremy S.
    Cui, Can
    Wei, Wei
    Thumar, Jaykumar Ranchobdhai
    Uboha, Nataliya, V
    Hafez, Navid
    Lacy, Jill
    Fischbach, Neal A.
    Sabbath, Kert D.
    Gomez, Christina M.
    Sporn, Jonathan Reed
    Stein, Stacey
    Hochster, Howard S.
    CANCER, 2021, 127 (09) : 1417 - 1424
  • [10] Phase 1b trial of nintedanib in combination with bevacizumab in patients with advanced solid tumors
    Ravi Paluri
    Ankit Madan
    Peng Li
    Benjamin Jones
    Mansoor Saleh
    Mary Jerome
    Deborah Miley
    Jennifer Keef
    Francisco Robert
    Cancer Chemotherapy and Pharmacology, 2019, 83 : 551 - 559
12345